Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Casgevy (exa-cel)
Pharma
Vertex adds CDMO Lonza to Casgevy production network
With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply chain.
Fraiser Kansteiner
Sep 24, 2024 9:41am
Bluebird down 18% with slow uptake of SCD gene therapy Lyfgenia
Aug 14, 2024 12:07pm
NICE signs off on Vertex, CRISPR's Casgevy for beta thalassemia
Aug 7, 2024 8:20pm
Vertex lifts sales guidance as Casgevy launch picks up
Aug 2, 2024 11:34am
Vertex files suit against US over access to fertility program
Jul 16, 2024 7:36am
Long-term data shows durability of Vertex's gene therapy Casgevy
Jun 14, 2024 11:12am
